The susceptibilities of 159 clinical isolates of glucose nonfermentative gramnegative bacilli were determined for eight new monobactam or P-lactam antibiotics. Imipemide (N-formimidoyl thienamycin) was effective against the largest number of species, although not against Pseudomonas maltophilia. Cefoperazone and ceftazidime, but not cefsulodin, were active against infrequently isolated Pseudomonas species. Aztreonam, moxalactam, cefotaxime, and ceftizoxime demonstrated selective activity against several species, including certain aminoglycoside-resistant isolates.
Members of the family Enterobacteriaceae and Pseudomonas aeruginosa are common causes of nosocomial infections. A wide variety of other aerobic gram-negative bacilli which are collectively characterized as being incapable of fermenting glucose, nonfermenters, are also encountered and are often resistant to extendedspectrum penicillins, first-and second-generation cephalosporins, or aminoglycosides (2, 4, 7, 12) . Newer-generation cephalosporins and related antibiotics containing a ,-lactam nucleus are highly active against many members of the Enterobacteriaceae and certain strains of P. aeruginosa (3, 4, 5, 8) . However, the activity of these newer agents against infrequently isolated nonfermenters is less clear.
In were susceptible (MIC90 s 8 ,ug/ml) to moxalactam, ceftazidime, and imipemide. Flavobacterium spp. were the most resistant of all species tested, with only ceftizoxime showing slightly greater activity than the other drugs tested.
The greater potency and broader spectrum of the new P-lactam antibiotics are presumably due to a variety offactors, including enhanced penetration through cell membrane barriers, greater affinity for critical binding proteins, and resistance to 1-lactamases (9) . Most of these antibiotics attain these characteristics through modifications in side chains attached to a common cephem nucleus which they share with older agents, whereas imipemide and moxalactam have slightly different basic structures (1). Aztreonam, a monobactam, has a fundamentally different structure in that the P-lactam ring is not attached to an adjacent five-or six-member ring as are all the P-lactam rings of the previously described P-lactam antibiotics. The spectrum of activity of this monocyclic ring depends upon the nature of the substituents. Aztreonam contains a side chain which confers excellent activity against aerobic gram-negative rods, Neisseria gonorrhoeae, and Haemophilus influenzae, but not gram-positive organisms or obligate anaerobes (1, 11) . The results of this study suggest that aztreonam and some of the newer cephalosporins are potentially useful therapeutic agents against the group of less frequently encountered aerobic gram-negative bacilli commonly referred to as nonfermenters. A. anitratus isolates, although previously shown to be highly resistant to firstand second-generation cephalosporins (2, 4), appear to be susceptible to ceftazidime and imipemide. Likewise, A. xylosoxidans, which is also resistant to first-and second-generation cephalosporins as well as aminoglycosides (2, 4, 12) , appears to be susceptible to moxalactam, cefoperazone, ceftazidime, and imipemide. Flavobacterium meningosepticum, commonly resistant to aminoglycosides, first-and secondgeneration cephalosporins, and extendedspectrum penicillins (2, 12) , was found in this study to be susceptible to ceftizoxime. P. cepacia isolates, which are similarly resistant to LiTERATURE CITED
